|
June 2026 CASE REPORT: ENDOSCOPIC ENDONASAL RESECTION OF AN OLFACTORY GROOVE SCHWANNOMA2-minute read
Schwannomas arising from the olfactory nerve are exceptionally rare, with fewer than 100 cases reported in the literature. Their presentation often overlaps with common sinonasal conditions, which can delay diagnosis and management. In this case, successful management required coordinated otolaryngology and neurosurgical expertise to address sinonasal and intracranial components through a unified surgical strategy. Case Presentation A female patient in her late 30’s presented with progressive nasal obstruction and loss of smell, symptoms initially consistent with common sinonasal conditions. Initial evaluation by several non-Northwestern Medicine clinicians led to management that included nasal sprays, saline irrigations and steroid therapy, with consideration given to post-viral anosmia and other benign etiologies. Despite appropriate treatment, her symptoms persisted. The patient was referred to Alexander L. Schneider, MD, a Northwestern Medicine otolaryngologist, and underwent CT imaging, which was largely inconclusive but raised concern for atypical findings. Due to lack of response to standard therapy and subtle abnormalities on CT, including bony irregularity, the patient was referred for MRI, which revealed an anterior skull base lesion, prompting biopsy.
Pathology confirmed a schwannoma, an uncommon diagnosis in this location. Given the rarity of olfactory nerve schwannomas, Dr. Schneider reviewed the case with Constantine Karras, MD, neurosurgeon. Surgical intervention was recommended because the tumor was benign and treatable with complete resection, which would relieve the patient’s progressive nasal obstruction. Surgical Approach The surgical team aimed to preserve nasal physiology and drainage pathways, minimize skull base disruption and maintain functional outcomes, including olfaction.
Outcomes
The patient continues to recover well and will undergo routine surveillance imaging and follow-up. Given the completeness of resection, no adjuvant therapy is required, and the risk of recurrence is considered very low, though ongoing monitoring is planned. Clinical Considerations
|
Constantine Karras, MD, Clinical Assistant Professor of Neurological Surgery at Northwestern Medicine
Alexander L. Schneider, MD, otolaryngologist at Northwestern Medicine
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
